Clinical Trial Update: A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome [Phase 2]

View source ↗

Summary

Phase II study evaluating allogeneic hematopoietic stem cell transplantation for VEXAS syndrome; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vexas Syndrome

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Immunodeficiency, Hematopoietic Stem Cell Transplantation | Phase 2 | Status: RECRUITING